Platelets: Qualitative & Quantitative Disorders Flashcards

1
Q

State three functions of von Willebrand Factor (vWF)

A
  • carrier protein for Factor VIII (VIII:C)
  • participates in Platelet’s adhesion to subendothelial collagen
  • Facilitates a normal aggregation response to ristocetin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Discuss von Willebrand disease: Pathogenesis

A

Clinical disorder due to deficiency of von Willebrand factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Discuss von Willebrand disease: Bleeding time results

A

Increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Discuss von Willebrand disease: closure time results (PFA)

A

Increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Discuss von Willebrand disease: platelet adhesion result

A

Abnormal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Discuss von Willebrand disease: platelet aggregation with ristocetin

A

Abnormal ristocetin induced aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Discuss von Willebrand disease: platelet count

A

can be normal or abnormal - not a hallmark

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Discuss von Willebrand disease: APTT result

A

Prolonged due to decrease VIII:C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Discuss Bernard-Soulier syndrome: Pathogenesis

A

Missing GPIb/IX receptor complex: Platelets cannot adhere to subendothelium via vWF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Discuss Bernard-Soulier syndrome: bleeding time result

A

Prolonged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Discuss Bernard-Soulier syndrome: platelet aggregation with ADP & ristocetin

A

ADP: normal
Ristocetin: Abnormal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Discuss Bernard-Soulier syndrome: platelet adhesion result

A

Abnormal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Discuss Bernard-Soulier syndrome: platelet count

A

Decreased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Discuss Bernard-Soulier syndrome: platelet morphology

A

Giant platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Discuss Glanzmann’s thrombasthenia: Pathogenesis

A

Missing GPIIb/IIIa receptor complex: platelets cannot bind to fibrinogen and bridge/attach to one another—aggregate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Discuss Glanzmann’s thrombasthenia: bleeding time result

A

Prolonged

17
Q

Discuss Glanzmann’s thrombasthenia: platelet adhesion result

A

Normal

18
Q

Discuss Glanzmann’s thrombasthenia: platelet aggregation with ADP and Ristocetin

A

ADP: abnormal
Ristocetin: normal

19
Q

Discuss Glanzmann’s thrombasthenia: platelet count

A

Normal

20
Q

Discuss Glanzmann’s thrombasthenia: platelet morphology

A

Normal

21
Q

List five acquired qualitative platelet disorders

A
  • drug therapy (most common cause)
  • Renal disease-uremia
  • Dysproteinemias
  • liver disease
  • platelet antibodies
22
Q

List four general causes for thrombocytopenia.

A
  • decreased platelet production
  • ineffective thrombopoiesis
  • abnormal distribution of platelets
  • increased destruction of platelets
23
Q

Destruction occurs by processes other than the immune system (consumption, mechanical destruction).

A

Non-immune mediated platelet destruction

24
Q

Platelets become sensitized with antibody and RES, especially the spleen, destroys them

A

immune mediated platelet destruction

25
Q

List three causes of non-immune mediated platelet destruction for thrombocytopenia

A
  • Thrombotic thrombocytopenic purpura (TTP)
  • Hemolytic uremic syndrome (HUS)
  • Disseminated intravascular coagulation (DIC)
26
Q

List three causes of immune mediated platelet destruction for thrombocytopenia

A
  • Idiopthic thrombocytopenic purpura (ITP)
  • drug-induced -> Heparin-induced thrombocytopenia (HIT)
  • Neonatal alloimmune thrombocytopenia